芬龙及其心脏脏保护作用:从随机试验中对21,731名患者的元分析
Bibeka Rai1, Salman Farooq Dar2, Moaz Alowami3
1From the Department of Care of the Elderly, Aneurin Bevan Health Board, Caerleon, United Kingdom.
Cardiology in review
|October 30, 2025
概括
芬龙是一种矿物质皮质类受体对手,在糖尿病和慢性病患者中显著减少心血管事件,心力衰竭住院和病进展. 虽然它通常是安全的,但它增加了高血症的风险.
科学领域:
- 心脏病学 心脏病学
- 腎臟病學 (nephrology) 是一種醫學專業.
- 内分泌学 在内分泌学.
背景情况:
- 菲内伦是一种非类固醇矿物质皮质类受体对抗剂.
- 它是糖尿病,慢性病 (CKD) 和心力衰竭 (HF) 患者的潜在治疗方法.
研究的目的:
- 总结一下目前关于finerenone心血管 (CV) 和脏功效的证据.
- 评估在糖尿病,慢性脏病和/或高血压症患者中芬瑞的疗效.
主要方法:
- 在PubMed,Cochrane CENTRAL,Embase和ClinicalTrials.gov的系统文献搜索,截至2024年7月21日.
- 使用随机效应模型对9项随机对照试验 (21,731名参与者) 的元分析.
- 评估的结果包括死亡率,主要的CV不良事件,HF住院和功能参数.
主要成果:
- 费内伦显著降低了全因死亡率 (RR,0.92),主要心血管不良事件 (RR,0.85) 和高频率住院治疗 (RR,0.82).
- 它减缓了估计的淋巴膜过率 (eGFR) 的下降 (MD,-1.65 mL/min/1.73m2/year) 并降低了尿中的白蛋白与肌素的比率 (MD, -0.28).
- 费内伦的高血症风险显著增加 (RR,2.05).
结论:
- 菲内伦具有显著的心脏和脏效益,改善了CKD,HF和糖尿病患者的治疗结果.
- 它是标准治疗的有效补充疗法,高胆固醇血风险增加是主要的安全问题.
- 这些发现支持芬在治疗心脏和脏疾病中的作用.
更多相关视频
09:02A Large Animal Model for Acute Kidney Injury by Temporary Bilateral Renal Artery Occlusion
Published on: February 2, 2021
4.8K
08:505/6th Nephrectomy in Combination with High Salt Diet and Nitric Oxide Synthase Inhibition to Induce Chronic Kidney Disease in the Lewis Rat
Published on: July 3, 2013
24.3K
相关概念视频
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
909
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
909
01:11Renal Failure: Dose Adjustments
426
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
426
01:22Heart Failure Drugs: Diuretics
788
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
788
01:25Antihypertensive Drugs: Direct Renin Inhibitors
1.3K
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
1.3K
01:30Heart Failure V: Medical Management
208
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
208
01:15Renal Drug Excretion: Overview
639
As primary excretory organs, the kidneys maintain homeostasis by removing waste substances from the bloodstream. They comprise over a million units called nephrons, which serve as the kidney's functional units.
A nephron consists of two primary structures: the renal corpuscle and the renal tubule. The renal corpuscle contains the glomerulus, a network of capillaries where the first step of renal excretion, glomerular filtration, occurs. Blood pressure forces water, ions, and small molecules...
A nephron consists of two primary structures: the renal corpuscle and the renal tubule. The renal corpuscle contains the glomerulus, a network of capillaries where the first step of renal excretion, glomerular filtration, occurs. Blood pressure forces water, ions, and small molecules...
639